InvestorsHub Logo
Followers 57
Posts 5697
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Tuesday, 09/30/2014 1:47:22 PM

Tuesday, September 30, 2014 1:47:22 PM

Post# of 345681
Maybe it is just my experience in investing and following many small biotechs...but I don't recall any of them that gave exact patient enrollment numbers....or details about "dozens" of collaborations...or gave anything but vague indications as to when an upcoming partnership deal would be signed. As far as I am concerned...I have gained some new information from every quarterly Conference Call and every ASM. Sometimes a person has to listen closely or read carefully...or follow what the analysts ask or what ASM attendees pick up...but in fact we have quite a lot of information...and there is a lot more coming. It is not a bad thing that we await a lot of news....it is a good thing...the company NOW has more preclinical and clinical trials than at any time in the past ten years of developing the anti-PS technology. Both pre-clinical and clinical trials take a lot of time. PPHM is not a "scratch and win" card...biotech investing requires patience. Good luck to all.

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News